Medicare Part D coverage · tizanidine · RxCUI 2723708

tizanidine 8 MG Oral Capsule

Per the CMS 2026 Part D formulary file, tizanidine 8 MG Oral Capsule is covered by 3 Medicare Part D plans (0.1% of enrollable products), averaging Tier 3, with prior authorization required on 0% of covering formularies.

0.1%
Plan coverage
3
Plans covering
T3
Avg tier
0%
Prior auth required

Verify with CMS →

Important: Drug coverage and costs vary by plan and location. Verify coverage directly with your Medicare plan before filling a prescription. This is informational data only and should not replace advice from your healthcare provider or pharmacist.

What the CMS Formulary Data Shows for tizanidine 8 MG Oral Capsule

Per the CMS 2026 Part D formulary file, tizanidine 8 MG Oral Capsule (RxNorm concept RXCUI 2723708, generic name tizanidine) appears on 1 distinct formulary file spanning 3 Medicare Part D plan offerings - 0.1% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 3 to Tier 3, with a cross-plan average of Tier 3.

Real-world access to tizanidine 8 MG Oral Capsule depends on utilization management as much as tier placement: 0% of covering formularies require prior authorization. 0% require step therapy. 0% apply quantity limits.

Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 1,905,964 Part D beneficiaries filled tizanidine 8 MG Oral Capsule in 2023, with total plan-and-beneficiary spending of $91,972,317 and an average per-beneficiary annual cost of $48.26. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry tizanidine 8 MG Oral Capsule today.

Coverage Details

Formularies covering
1
Plans covering
3
Coverage rate
0.1%
Tier range
Tier 3, Preferred Brand
Average tier
Tier 3, Preferred Brand

Restrictions

Prior authorization required
0% of formularies
Step therapy required
0% of formularies
Quantity limits
0% of formularies

2023 Medicare Spending

Beneficiaries
1,905,964
Total spending
$91,972,317
Avg per beneficiary
$48.26

Tier Distribution Across Plans

3 plans
Tier 3, Preferred Brand

Medicare Advantage Plans (MA-PD) Covering tizanidine 8 MG Oral Capsule

3 Medicare Advantage plans with Part D drug coverage include this drug.

Plan Insurer Tier PA Premium States
PrimeTime Health Plan Aultimate (HMO-POS) Aultcare Health Insuring Corporation T3 No $0 OH
PrimeTime Health Plan Plus (HMO-POS) Aultcare Health Insuring Corporation T3 No $36.00 OH
PrimeTime Health Plan Classic (HMO-POS) Aultcare Health Insuring Corporation T3 No $40.30 OH

Frequently Asked Questions

Is tizanidine 8 MG Oral Capsule covered by Medicare Part D?

Yes, tizanidine 8 MG Oral Capsule is covered by 3 Medicare Part D plans (0.1% of all Part D formularies).

What tier is tizanidine 8 MG Oral Capsule on Medicare Part D plans?

tizanidine 8 MG Oral Capsule averages Tier 3 across Part D plans, ranging from Tier 3 to Tier 3.

Does tizanidine 8 MG Oral Capsule require prior authorization?

0% of Part D formularies require prior authorization for tizanidine 8 MG Oral Capsule. Step therapy: 0%. Quantity limits: 0%.

How much does Medicare spend on tizanidine 8 MG Oral Capsule?

In 2023, total Medicare Part D spending on tizanidine 8 MG Oral Capsule was $91,972,317, covering 1,905,964 beneficiaries. The average spend per beneficiary was $48.26.

Read our methodology - how this data is sourced, computed, and verified.

Nationwide similar Part D drugs

Data-derived peers across the CMS Part D formulary extract: nearest average tier placement and nearest prior-authorization rate. Not therapeutic alternatives or same-generic strengths.

Closest average formulary tier

Similar prior-authorization rate

Data sourced from the Centers for Medicare & Medicaid Services (CMS). See our methodology for details. Retrieved and formatted by PlainMedicare